Characterization of viability and proliferation of alginate-poly-L-lysine- alginate encapsulated myoblasts using flow cytometry

Ajit Thakur, Ruchira Sengupta, Hideto Matsui, David Lillicrap, Kim Jones, Gonzalo Hortelano

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Genetically modified cells encapsulated in alginatepoly-L-lysine-alginate (APA) are being developed to deliver therapeutic products to treat a variety of diseases. The characterization of the encapsulated cells thus becomes paramount. This study reports a novel method to assess the viability, granularity and proliferation of encapsulated cells based on flow cytometry. The in vitro viability of encapsulated G8 murine myoblasts secreting canine FVIII (cFVIII) measured by flow cytometry was comparable to the traditional trypan blue exclusion method and both correlated with cFVIII secretion levels. In contrast, after implantation into mice, only viability measured by flow cytometry correlated with cFVIII secretion. Further, flow cytometry analysis of encapsulated cells maintained in vitro and in vivo revealed a greater fraction of granular cells compared to free cells, suggesting that encapsulation influences the morphology (cytoplasmic composition) of cells within APA microcapsules. Interestingly, the proliferation study showed that encapsulated cells proliferate faster, on average, and were more heterogeneous in vivo compared to in vitro culture conditions, suggesting that encapsulated cell proliferation is complex and environment-dependent. In conclusion, we show that flow cytometry analysis allows for a more consistent and comprehensive examination of encapsulated cells to aid in the development of cell therapy protocols.

Original languageEnglish
Pages (from-to)296-304
Number of pages9
JournalJournal of Biomedical Materials Research - Part B Applied Biomaterials
Volume94
Issue number2
DOIs
Publication statusPublished - 2010
Externally publishedYes

Fingerprint

Flow cytometry
Myoblasts
Alginate
Flow Cytometry
Lysine
Canidae
Trypan Blue
Cell proliferation
Encapsulation
Cell culture
Cell Proliferation
Capsules
alginate-polylysine-alginate
Cell- and Tissue-Based Therapy
Chemical analysis

Keywords

  • Alginate-poly-L-lysine-alginate
  • Gene therapy
  • Granularity
  • Myoblasts
  • Proliferation
  • Viability

ASJC Scopus subject areas

  • Biomedical Engineering
  • Biomaterials
  • Medicine(all)

Cite this

Characterization of viability and proliferation of alginate-poly-L-lysine- alginate encapsulated myoblasts using flow cytometry. / Thakur, Ajit; Sengupta, Ruchira; Matsui, Hideto; Lillicrap, David; Jones, Kim; Hortelano, Gonzalo.

In: Journal of Biomedical Materials Research - Part B Applied Biomaterials, Vol. 94, No. 2, 2010, p. 296-304.

Research output: Contribution to journalArticle

@article{2f759c0986774fbf8ea6ee33588c6d23,
title = "Characterization of viability and proliferation of alginate-poly-L-lysine- alginate encapsulated myoblasts using flow cytometry",
abstract = "Genetically modified cells encapsulated in alginatepoly-L-lysine-alginate (APA) are being developed to deliver therapeutic products to treat a variety of diseases. The characterization of the encapsulated cells thus becomes paramount. This study reports a novel method to assess the viability, granularity and proliferation of encapsulated cells based on flow cytometry. The in vitro viability of encapsulated G8 murine myoblasts secreting canine FVIII (cFVIII) measured by flow cytometry was comparable to the traditional trypan blue exclusion method and both correlated with cFVIII secretion levels. In contrast, after implantation into mice, only viability measured by flow cytometry correlated with cFVIII secretion. Further, flow cytometry analysis of encapsulated cells maintained in vitro and in vivo revealed a greater fraction of granular cells compared to free cells, suggesting that encapsulation influences the morphology (cytoplasmic composition) of cells within APA microcapsules. Interestingly, the proliferation study showed that encapsulated cells proliferate faster, on average, and were more heterogeneous in vivo compared to in vitro culture conditions, suggesting that encapsulated cell proliferation is complex and environment-dependent. In conclusion, we show that flow cytometry analysis allows for a more consistent and comprehensive examination of encapsulated cells to aid in the development of cell therapy protocols.",
keywords = "Alginate-poly-L-lysine-alginate, Gene therapy, Granularity, Myoblasts, Proliferation, Viability",
author = "Ajit Thakur and Ruchira Sengupta and Hideto Matsui and David Lillicrap and Kim Jones and Gonzalo Hortelano",
year = "2010",
doi = "10.1002/jbm.b.31648",
language = "English",
volume = "94",
pages = "296--304",
journal = "Journal of Biomedical Materials Research - Part B Applied Biomaterials",
issn = "1552-4973",
publisher = "John Wiley and Sons Inc.",
number = "2",

}

TY - JOUR

T1 - Characterization of viability and proliferation of alginate-poly-L-lysine- alginate encapsulated myoblasts using flow cytometry

AU - Thakur, Ajit

AU - Sengupta, Ruchira

AU - Matsui, Hideto

AU - Lillicrap, David

AU - Jones, Kim

AU - Hortelano, Gonzalo

PY - 2010

Y1 - 2010

N2 - Genetically modified cells encapsulated in alginatepoly-L-lysine-alginate (APA) are being developed to deliver therapeutic products to treat a variety of diseases. The characterization of the encapsulated cells thus becomes paramount. This study reports a novel method to assess the viability, granularity and proliferation of encapsulated cells based on flow cytometry. The in vitro viability of encapsulated G8 murine myoblasts secreting canine FVIII (cFVIII) measured by flow cytometry was comparable to the traditional trypan blue exclusion method and both correlated with cFVIII secretion levels. In contrast, after implantation into mice, only viability measured by flow cytometry correlated with cFVIII secretion. Further, flow cytometry analysis of encapsulated cells maintained in vitro and in vivo revealed a greater fraction of granular cells compared to free cells, suggesting that encapsulation influences the morphology (cytoplasmic composition) of cells within APA microcapsules. Interestingly, the proliferation study showed that encapsulated cells proliferate faster, on average, and were more heterogeneous in vivo compared to in vitro culture conditions, suggesting that encapsulated cell proliferation is complex and environment-dependent. In conclusion, we show that flow cytometry analysis allows for a more consistent and comprehensive examination of encapsulated cells to aid in the development of cell therapy protocols.

AB - Genetically modified cells encapsulated in alginatepoly-L-lysine-alginate (APA) are being developed to deliver therapeutic products to treat a variety of diseases. The characterization of the encapsulated cells thus becomes paramount. This study reports a novel method to assess the viability, granularity and proliferation of encapsulated cells based on flow cytometry. The in vitro viability of encapsulated G8 murine myoblasts secreting canine FVIII (cFVIII) measured by flow cytometry was comparable to the traditional trypan blue exclusion method and both correlated with cFVIII secretion levels. In contrast, after implantation into mice, only viability measured by flow cytometry correlated with cFVIII secretion. Further, flow cytometry analysis of encapsulated cells maintained in vitro and in vivo revealed a greater fraction of granular cells compared to free cells, suggesting that encapsulation influences the morphology (cytoplasmic composition) of cells within APA microcapsules. Interestingly, the proliferation study showed that encapsulated cells proliferate faster, on average, and were more heterogeneous in vivo compared to in vitro culture conditions, suggesting that encapsulated cell proliferation is complex and environment-dependent. In conclusion, we show that flow cytometry analysis allows for a more consistent and comprehensive examination of encapsulated cells to aid in the development of cell therapy protocols.

KW - Alginate-poly-L-lysine-alginate

KW - Gene therapy

KW - Granularity

KW - Myoblasts

KW - Proliferation

KW - Viability

UR - http://www.scopus.com/inward/record.url?scp=77955360629&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77955360629&partnerID=8YFLogxK

U2 - 10.1002/jbm.b.31648

DO - 10.1002/jbm.b.31648

M3 - Article

VL - 94

SP - 296

EP - 304

JO - Journal of Biomedical Materials Research - Part B Applied Biomaterials

JF - Journal of Biomedical Materials Research - Part B Applied Biomaterials

SN - 1552-4973

IS - 2

ER -